Effect of fucoxanthin on the metabolic syndrome, insulin sensitivity and insulin secretion
Metabolic Syndrome
Enrolment: 28 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Metabolic Syndrome
Enrolment: 28 · Results not recorded
Non Alcoholic Fatty Liver
Enrolment: 30 · Results not recorded
Non-alcoholic Fatty Liver Disease
Enrolment: 57 · Results not recorded
Overweight and Obesity · Body Weight Changes
Enrolment: 60 · Results not recorded
Cognitive Function
Enrolment: 60 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Experimental subarachnoid haemorrhage, with parallel experiments in primary cultured neurons
Fucoxanthin inhibited reactive oxygen species production and lipid peroxidation after subarachnoid haemorrhage, restored endogenous antioxidant enzyme activities, improved mitochondrial morphology, reduced neuronal apoptosis and brain oedema, and improved short-term and long-term neurobehavioural f…
Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.